The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEurocell Regulatory News (ECEL)

Share Price Information for Eurocell (ECEL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 135.00
Bid: 134.00
Ask: 136.00
Change: 0.00 (0.00%)
Spread: 2.00 (1.493%)
Open: 135.00
High: 135.50
Low: 131.00
Prev. Close: 135.00
ECEL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Launch of Share Buyback Programme

23 Jan 2024 07:00

RNS Number : 5275A
Eurocell plc
23 January 2024
 

23 January 2024

 

EUROCELL PLC

("Eurocell" or the "Group")

 

Launch of Share Buyback Programme

 

Eurocell plc, the market leading, vertically integrated UK manufacturer, recycler and distributor of innovative window, door and roofline PVC products, today announced that it intends to commence a new share buyback programme in respect of its ordinary shares of £0.001 each ("Ordinary Shares") up to a maximum consideration of £5 million from the date of this announcement (the "Buyback").

 

As referenced in today's Year End Trading Update, the Board is focused on enhancing shareholder returns and recognises the importance of our ordinary dividend. We will also periodically consider supplementary distributions, whilst always seeking to maintain a strong financial position. The Buyback will reduce the share capital of the Company and enhance earnings per share.

 

Details of the Share Buyback Programme

Eurocell has given irrevocable and non-discretionary instructions to Peel Hunt LLP ("Peel Hunt") in relation to the Buyback, which will commence on 23 January 2024. Peel Hunt will act as principal during the Buyback and will make trading decisions concerning the timing of the purchases of Ordinary Shares independently of the Company.

 

The maximum amount allocated to the Buyback is £5 million. Any market repurchase of Ordinary Shares will be announced no later than 7:30am on the business day following the calendar day on which the repurchase occurred. The first 642,000 Ordinary Shares that are repurchased will be held in treasury to satisfy employee share options over the next two years whilst any further Ordinary Shares that are repurchased will be cancelled.

 

Any purchases of Ordinary Shares contemplated by this announcement will be effected within certain pre-set parameters. These arrangements are in accordance with the authorities granted by the Company's shareholders at its annual general meeting held on 11 May 2023 to repurchase a maximum of 11,209,518 Ordinary Shares.

 

The maximum price payable for an Ordinary Share will be the lower of (a) 105% of the average of the middle market quotation for Ordinary Shares as derived from the Daily Official List of London Stock Exchange plc for the five business days before the date on which the purchase is made and (b) an amount equal to the higher of the last independent trade and highest current independent purchase bid.

 

Due to the limited liquidity in the Ordinary Shares, the Buyback may on any given trading day exceed 25 per cent but remain below 50 per cent of the average daily trading volume.

 

The arrangements relating to the maximum price and volume parameters are in accordance with Article 5(1) in the UK version of the Market Abuse Regulations (Regulation (EU) No 596/2014) as incorporated into UK domestic law by virtue of the European Union (Withdrawal) Act 2018. The limited liquidity of the Company allows for Market Abuse Regulations 1 Annex 1.1.9.3(b) Provision of the Buy-back and Stabilisation Regulation relating to buy-back programmes to warrant the exemptions specified.

 

Details of the authority granted at the 2023 AGM can be found on our website under: https://investors.eurocell.co.uk/investors/agm/

 

This announcement contains inside information for the purposes of the Market Abuse Regulation (EU) no. 596/2014 (including as it forms part of the laws of England and Wales by virtue of the European Union (Withdrawal) Act 2018) ('MAR').

 

 

Enquiries:

Eurocell plc

Darren Waters, Chief Executive Officer +44 (0) 1773 842 105

Michael Scott, Chief Financial Officer +44 (0) 1773 842 140

 

Teneo

Nick de Bunsen +44 (0) 7825 575 258

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSVLLFLZFLXBBK
Date   Source Headline
15th Nov 20227:04 amRNSHolding(s) in Company
14th Nov 20227:00 amRNSHolding(s) in Company
10th Nov 20224:00 pmRNSHolding(s) in Company
8th Nov 20223:59 pmRNSDirectorate Change
26th Oct 20227:00 amRNSHolding(s) in Company
7th Oct 20227:00 amRNSChanges to Board Committee memberships
5th Oct 20222:00 pmRNSHolding(s) in Company
3rd Oct 20227:00 amRNSTotal Voting Rights
5th Sep 20227:00 amRNSBlock listing Interim Review
5th Sep 20227:00 amRNSInvestor Presentation
1st Sep 20227:00 amRNSHalf-year Report
15th Aug 20223:00 pmRNSHolding(s) in Company
10th Aug 20223:45 pmRNSAppointment to the Audit & Risk Committee
13th Jul 20227:00 amRNSTrading Update
5th Jul 202212:25 pmRNSHolding(s) in Company
1st Jul 20227:00 amRNSTotal Voting Rights
22nd Jun 20227:00 amRNSDirector/PDMR Shareholding
21st Jun 202212:08 pmRNSDirectorate Change
25th May 20227:00 amRNSBlock Listing Application
16th May 20227:00 amRNSDirector/PDMR Shareholding
12th May 20224:00 pmRNSResult of AGM
12th May 20227:00 amRNSAGM Trading Update and Board Update
14th Apr 20224:00 pmRNSDirector/PDMR Shareholding
14th Apr 20224:00 pmRNSDirector/PDMR Shareholding
8th Apr 20227:00 amRNSAnnual Financial Report
21st Mar 20227:00 amRNSInvestor Presentation
18th Mar 20227:00 amRNSPreliminary results for the year ended 31 Dec 2021
17th Mar 20227:00 amRNSNotice of Results and Audiocast
15th Mar 20223:05 pmRNSTransaction in Own Shares
9th Mar 20225:00 pmRNSBlock listing Interim Review
16th Feb 20227:00 amRNSAppointment of Joint Corporate Broker
21st Jan 20227:00 amRNSYear End Trading Update
4th Jan 20227:00 amRNSTotal Voting Rights
1st Dec 20217:00 amRNSTotal Voting Rights
24th Nov 20217:00 amRNSTrading Update November 2021
1st Nov 20217:00 amRNSTotal Voting Rights
1st Oct 20217:00 amRNSTotal Voting Rights
7th Sep 20214:00 pmRNSInvestor Presentation
7th Sep 20211:38 pmRNSBlock listing Interim Review
3rd Sep 20217:00 amRNSHalf-year Report
1st Sep 20217:00 amRNSTotal Voting Rights
2nd Aug 20217:00 amRNSTotal Voting Rights
20th Jul 20217:00 amRNSTrading Update
1st Jul 20217:00 amRNSTotal Voting Rights
1st Jun 20217:00 amRNSTotal Voting Rights
14th May 202111:18 amRNSResult of AGM
13th May 20217:00 amRNSAGM Trading Update – Strong First Four Months
12th May 20216:13 pmRNSDirector/PDMR Shareholding
4th May 20217:00 amRNSTotal Voting Rights
26th Apr 20219:40 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.